HK Stock Movement | GenFleet Therapeutics-B (02595.HK) Surges Over 7% in Early Trading; GFH375 Combined with Cetuximab Combination Therapy Proposed for Breakthrough Therapy Designation List

Zhito Finance APP has learned that GenFleet Therapeutics-B (02595.HK) rose more than 7% in early trading. As of press time, it was up 7.45%, at HK$30.58, with a turnover of HK$9.0276 million.